Covered recipient · General Payments record
AMANDA K SHIPP
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2023
$977.49
- Reported across 62 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $268.48 | 17 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $96.35 | 6 |
| Acerta Pharma LLC | $63.91 | 4 |
| PFIZER INC. | $41.95 | 3 |
| Mylan Specialty L.P. | $19.45 | 1 |
| Exact Sciences Corporation | $18.29 | 1 |
| Lilly USA, LLC | $14.41 | 1 |
| Otsuka America Pharmaceutical, Inc. | $14.12 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $16.80 | 01/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998981270 | CMS |
| AbbVie Inc. | $17.98 | 02/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998981273 | CMS |
| AbbVie Inc. | $16.56 | 03/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998981277 | CMS |
| AbbVie Inc. | $17.07 | 05/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998981281 | CMS |
| AbbVie Inc. | $12.72 | 10/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998981285 | CMS |
| AbbVie Inc. | $15.22 | 12/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998981289 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.68 | 04/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1012028021 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.49 | 05/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015957941 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.34 | 10/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015805743 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.40 | 10/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015664697 | CMS |
| Exact Sciences Corporation | $18.29 | 02/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026529261 | CMS |
| Lilly USA, LLC | $14.41 | 03/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031237587 | CMS |
| Mylan Specialty L.P. | $19.45 | 08/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1039108269 | CMS |
| Otsuka America Pharmaceutical, Inc. | $14.12 | 03/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014814415 | CMS |
| PFIZER INC. | $13.97 | 03/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050397335 | CMS |
| PFIZER INC. | $14.50 | 04/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050518169 | CMS |
| PFIZER INC. | $13.48 | 09/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049258021 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.